Company / AR per Share
Summit Therapeutics Inc. AR per Share History
FY2019-FY2023 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest AR per Share
-
FY2023
5-year range
$0.00 / $0.00
FY2019-FY2023
Trend
-100.0%
vs FY2022
Sector context
#114 of 113
Health Care
What the data says
Declined from $0.00 to $0.00 over the past 2 years.
Health Care sector context is included.
AR per Share over time
Growth rates
- 3-Year CAGR
- -
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Sector benchmark
Bottom -1% in Health CareTop 101% of 113
▼
Key checks
Key Insights
- Summit Therapeutics Inc.'s ar per share has declined for 4 consecutive years.
- In FY2023, ar per share decreased 100.0% year-over-year.
- Peak ar per share was recorded in FY2019.
Company context
Key Data Points
- Low Piotroski F-Score: 1/9 (multiple financial health concerns)
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | AR per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | - | - |
| FY2024 | - | - |
| FY2023 | $0.00 | -100.0% |
| FY2022 | $0.00 | -18.3% |
| FY2021 | $0.00 | -11.6% |
| FY2020 | $0.00 | -70.1% |
| FY2019 | $0.02 | - |
| FY2018 | - | - |
As of FY2023 · SEC 10-K · Updated Jun 30, 2026